Back

Aspirin for primary prevention in patients with diabetes according to lipoprotein(a) levels: a real-world propensity-matched analysis

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Lipid lowering (2) Drug therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Amir Askarinejad

Institute of Life Course and Medical Sciences, Liverpool (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Longitudinal trends in statin prescribing and LDL-C control prior to acute myocardial infarction (AMI) in France: we continue to “miss the mark”
Doctor P. PIRIOU (Paris, FR)
Abstract Slides
Presentation thumbnail
Sex- and age-based disparities in statin use in patients admitted for acute myocardial infarction in France: two decades of failure ?
Doctor P. PIRIOU (Paris, FR)
Abstract Slides
Presentation thumbnail
Association between remnant cholesterol levels and the in-hospital outcomes and long-term prognosis in ST-segment elevated myocardial infarction patients
Ms H. Chen (CN)
Abstract Slides
Presentation thumbnail
Intensive lipid lowering therapy improves microvascular function assessed by retinal vessel analysis in patients after ST-elevation myocardial infarction
Doctor D. Hanke (Jena, DE)
Abstract Slides
Presentation thumbnail
Changes in lipoprotein(a) levels in younger patients following ST-elevation myocardial infarction
Doctor J. Yoon (Vancouver, CA)
Abstract Slides

Access the full session

Session thumbnail
Lipid lowering (2)

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Aspirin use for prevention of cardiovascular events in patients with high lipoprotein(a): a population-based study
3 September 2019
thumbnail
Congress Presentation
Association of diabetes mellitus status and clinical outcomes of edoxaban in patients with atrial fibrillation: a sub-analysis from the ETNA-AF Asian registry
12 April 2026
thumbnail
Congress Presentation
Effect of LPA gene on CAD risk among diabetic patients
3 September 2019
thumbnail
Congress Presentation
To improve the quality of secondary prevention strategies in diabetic patients: the BRING-UP Prevention study results
5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources